New biomedical technologies are on the cusp of dramatically impacting not only healthcare and how we treat disease, but life itself. Visionary biologist, Andrew Hessel, spoke at our May What’s Now: San Francisco session exploring the extraordinary potential—and potential drawbacks—of gene editing and 3D printing in the field of biotech.